Alzheimer's disease and language impairments: social intervention and medical treatment.
Blanka Klimova, Petra Maresova, Martin Valis...
https://pubmed.ncbi.nlm.nih.gov/26346123Actively Recruiting
Led by University of Texas at Austin · Updated on 2025-11-12
60
Participants Needed
3
Research Sites
N/A
Total Duration
U
University of Texas at Austin
Lead Sponsor
F
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsor
Researchers are studying bilingual individuals with primary progressive aphasia (PPA), a condition marked by difficulties in speech and language. This trial evaluates the effects of speech-language treatments tailored to the cultural and linguistic backgrounds of bilingual speakers with PPA. It aims to understand how bilingual experiences, like language use and strength, relate to treatment response and to explore brain mechanisms involved in language recovery and resilience in PPA. The study includes two main behavioral interventions based on PPA variant types. Participants with nonfluent/agrammatic PPA engage in Video-Implemented Script Training for Aphasia (VISTA), practicing personally relevant scripts via teletherapy and independent computer exercises. Those with logopenic or semantic variant PPA receive Lexical Retrieval Training (LRT), focusing on word retrieval strategies through teletherapy and computer-based practice. These treatments occur over several weeks with assessments before, after, and at 6- and 12-month follow-ups. Additionally, some participants undergo brain imaging before treatment. Participants complete regular evaluations of speech intelligibility and naming ability, along with questionnaires and speech feature analyses at multiple time points. The study monitors treatment effects through teletherapy sessions, independent practice, and structured language assessments. Safety and progress are tracked throughout the study, which lasts over a year to capture both immediate and longer-term outcomes of the tailored speech-language interventions.
CONDITIONS
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 9 weeks
Participants complete teletherapy sessions and independent computer-based practice tailored to their type of primary progressive aphasia to improve speech and language abilities.
Two 1-hour teletherapy sessions per week plus independent 30-minute computer-based practice 5-7 times per week
Duration - Up to 1 year post-treatment
Participants are assessed at multiple time points after treatment to monitor the progress and effects of the intervention on speech and language abilities.
Assessments at 6 months and 1 year post-treatment
Total: 3 locations
1
University of Texas at Austin
Austin, Texas, United States, 78752
Actively Recruiting
2
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain, 08025
Actively Recruiting
3
Hospital Clínic de Barcelona
Barcelona, Spain, 08036
Not Yet Recruiting
C
Camille Wagner Rodríguez, M.S., CCC-SLP
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Blanka Klimova, Petra Maresova, Martin Valis...
https://pubmed.ncbi.nlm.nih.gov/26346123Greta Szatloczki, Ildiko Hoffmann, Veronika Vincze...
https://pubmed.ncbi.nlm.nih.gov/26539107M M Mesulam
https://pubmed.ncbi.nlm.nih.gov/7114808Maxime Montembeault, Simona M Brambati, Maria Luisa Gorno-Tempini...
https://pubmed.ncbi.nlm.nih.gov/30186225M L Gorno-Tempini, A E Hillis, S Weintraub...
https://pubmed.ncbi.nlm.nih.gov/21325651Maria Teresa Carthery-Goulart, Amanda da Costa da Silveira, Thais Helena Machado...
https://pubmed.ncbi.nlm.nih.gov/29213828Ellen Bialystok, Fergus I M Craik, Morris Freedman
https://pubmed.ncbi.nlm.nih.gov/17125807Suvarna Alladi, Thomas H Bak, Mekala Shailaja...
https://pubmed.ncbi.nlm.nih.gov/28322905Suvarna Alladi, Thomas H Bak, Vasanta Duggirala...
https://pubmed.ncbi.nlm.nih.gov/24198291Jessica de Leon, Stephanie M Grasso, Ariane Welch...
https://pubmed.ncbi.nlm.nih.gov/32881346